ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EXO Exova Grp

238.50
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Exova Grp LSE:EXO London Ordinary Share GB00BKY7HG11 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 238.50 239.00 239.75 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Exova Group PLC Changes to Nomination Committee (4985S)

21/12/2016 12:06pm

UK Regulatory


Exova (LSE:EXO)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Exova Charts.

TIDMEXO

RNS Number : 4985S

Exova Group PLC

21 December 2016

EXOVA GROUP PLC

Changes to Nomination Committee

Exova Group plc announces that with effect from 20 December 2016, Bill Spencer, Senior Independent Non-Executive Director, and Vanda Murray, Independent Non-Executive Director, joined the Nomination Committee. The Nomination Committee now comprises Allister Langlands (Chairman of the Board and the Nomination Committee), Bill Spencer (Senior Independent Non-Executive Director), Helmut Eschwey (Independent Non-Executive Director), Vanda Murray (Independent Non-Executive Director) and Fred Kindle (Non-Executive Director). The composition of the Nomination Committee is in line with provision B.2.1 of the UK Corporate Governance Code.

For and on behalf of Exova Group plc

Date: 21 December 2016

Neil MacLennan

General Counsel & Company Secretary

Telephone: 0131 333 8053

About Exova

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 134 laboratories and offices in 33 countries and employs more than 4,300 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Automotive; and Health Sciences.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCBDBDDXGDBGLB

(END) Dow Jones Newswires

December 21, 2016 07:06 ET (12:06 GMT)

1 Year Exova Chart

1 Year Exova Chart

1 Month Exova Chart

1 Month Exova Chart

Your Recent History

Delayed Upgrade Clock